BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34403895)

  • 1. Simulated driving performance among daily and occasional cannabis users.
    Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
    Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis effects on driving lateral control with and without alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
    Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cannabis use history on the impact of acute cannabis smoking on simulated driving performance during a distraction task.
    Miller R; Brown T; Wrobel J; Kosnett MJ; Brooks-Russell A
    Traffic Inj Prev; 2022; 23(sup1):S1-S7. PubMed ID: 35686998
    [No Abstract]   [Full Text] [Related]  

  • 5. The failings of
    Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
    Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive.
    Miller R; Brown T; Schmitt R; Gaffney G; Milavetz G
    Accid Anal Prev; 2024 Feb; 195():107376. PubMed ID: 37984112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
    Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
    Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance.
    Manning B; Arkell TR; Hayley AC; Downey LA
    J Psychopharmacol; 2024 Mar; 38(3):247-257. PubMed ID: 38332655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial.
    Marcotte TD; Umlauf A; Grelotti DJ; Sones EG; Sobolesky PM; Smith BE; Hoffman MA; Hubbard JA; Severson J; Huestis MA; Grant I; Fitzgerald RL
    JAMA Psychiatry; 2022 Mar; 79(3):201-209. PubMed ID: 35080588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis effects on driving longitudinal control with and without alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
    J Appl Toxicol; 2016 Nov; 36(11):1418-29. PubMed ID: 26889769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking.
    Kosnett MJ; Ma M; Dooley G; Wang GS; Friedman K; Brown T; Henthorn TK; Brooks-Russell A
    Clin Toxicol (Phila); 2023 May; 61(5):355-362. PubMed ID: 37293900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of THC Cutoff Levels in Blood and Saliva for Detection of Impaired Driving.
    Di Ciano P; Brands B; Fares A; Wright M; Stoduto G; Byrne P; McGrath M; Hasan OSM; Le Foll B; Wickens CM
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):408-413. PubMed ID: 36730769
    [No Abstract]   [Full Text] [Related]  

  • 13. Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial.
    Hartley S; Simon N; Cardozo B; Larabi IA; Alvarez JC
    Front Public Health; 2023; 11():1234765. PubMed ID: 38074719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and Driving in Older Adults.
    Di Ciano P; Rajji TK; Hong L; Zhao S; Byrne P; Elzohairy Y; Brubacher JR; McGrath M; Brands B; Chen S; Wang W; Hasan OSM; Wickens CM; Kaduri P; Le Foll B
    JAMA Netw Open; 2024 Jan; 7(1):e2352233. PubMed ID: 38236599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers.
    Hoffman MA; Hubbard JA; Sobolesky PM; Smith BE; Suhandynata RT; Sanford S; Sones EG; Ellis S; Umlauf A; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
    J Anal Toxicol; 2021 Sep; 45(8):851-862. PubMed ID: 34173005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Smoked Cannabis on Vigilance and Accident Risk Using Simulated Driving in Occasional and Chronic Users and the Pharmacokinetic-Pharmacodynamic Relationship.
    Hartley S; Simon N; Larabi A; Vaugier I; Barbot F; Quera-Salva MA; Alvarez JC
    Clin Chem; 2019 May; 65(5):684-693. PubMed ID: 30872375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests.
    Fitzgerald RL; Umlauf A; Hubbard JA; Hoffman MA; Sobolesky PM; Ellis SE; Grelotti DJ; Suhandynata RT; Huestis MA; Grant I; Marcotte TD
    Clin Chem; 2023 Jul; 69(7):724-733. PubMed ID: 37228223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects.
    Brands B; Mann RE; Wickens CM; Sproule B; Stoduto G; Sayer GS; Burston J; Pan JF; Matheson J; Stefan C; George TP; Huestis MA; Rehm J; Le Foll B
    Drug Alcohol Depend; 2019 Dec; 205():107641. PubMed ID: 31678833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
    Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
    Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking.
    Rague JM; Ma M; Dooley G; Wang GS; Friedman K; Henthorn TK; Brooks-Russell A; Kosnett MJ
    Clin Toxicol (Phila); 2023 May; 61(5):363-369. PubMed ID: 36939145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.